NCEH1 and prostate neoplasm: Investigation shows that KIAA1363 is likely linked to NCEH1 pathways, as KIAA1363 inhibition results in prostate tumor suppression activity in vivo, likely through downregulation of monoalkylglycerol ether classes of neutral ether lipids [99].